Wolfgang Huber

Group Leader and Senior Scientist
More …

Simone Bell

Simone has a degree in Nutrition Sciences and Home Economics from the Niederrhein University of Applied Sciences, Mönchengladbach. She acts as Projects and Communications Officer.
More …

Constantin Ahlmann-Eltze

Constantin joined the Huber Group in July 2019 as PhD student and his work focuses on statistical method development for biological data. He received his Master degree in Molecular Biotechnology from the Heidelberg University. During his Master thesis, he worked on the development of statistical tests for label-free mass spectrometry data.

Hosna Baniadam

Hosna is enrolled in Strasbourg University’s double degree program, allowing her to follow a medical degree and a master’s degree in bioinformatics at the same time. After an internship in Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), where she studied the transcriptomic profile of T-cell subtypes in B-cell non-Hodgkin lymphoma, she joined the Huber group in January 2021 for her master thesis and is working on statistical method development for single-cell data.

Klemens Tümay Capraz

Tümay studied Biotechnology at the University of Natural Resources and Life Sciences (BOKU) in Vienna. For his master thesis he worked on a high-throughput method for protein complex localization assignment at ETH Zurich. In October 2020 he joined the Huber group as a PhD student to work on the development of new statistical and machine-learning methods for the analysis of multi-omics data.

Donnacha Fitzgerald

After completing his pharmacy studies at University College Cork and the Royal College of Surgeons in Ireland, Donnacha joined the Huber group in October 2019 for a joint PhD with the Dietrich group at the National Centre for Tumour Diseases in Heidelberg. His current research focuses on using single-cell multi-omics to understand intra-tumour heterogeneity of drug response in blood cancers.

Holly Giles

Holly graduated from the University of Cambridge with a degree in Natural Sciences. For her thesis, she investigated the within-host diversity of influenza infections using statistical methods. In 2016, she undertook an internship at the Francis Crick Institute, London, during which she investigated potential new methods of influenza surveillance and vaccine research.
More …

Alexander Helmboldt

Alex received his PhD in theoretical particle physics from the University of Heidelberg and the Max Planck Institute for Nuclear Physics before he joined the Huber group as postdoc fellow in February 2020. As a member of the DECODE project, his current research focuses on single-cell analyses and the development of statistical methods for biological data.

Nick Hirschmüller

Nick is currently enrolled in the Cancer Biology Masters Program at the Heidelberg University. He joined the Huber Group in May 2021 after a research internship at the German Cancer Research Center, where he analysed the prevalence of selection in premalignant skin. During his stay at EMBL, he will assess the germline genetic component of the proliferation drive in Chronic Lymphocytic Leukemia.

Katharina Imkeller

Katharina received her PhD in Immunology from Heidelberg University for her work on human antibody repertoires in Malaria infection. In June 2018 she joined a collaborative research project between the Huber group at EMBL and the Boutros group at the German Cancer Research Center. Her current research focuses on mapping and understanding genetic interactions in the context of disease.

Sarah Kaspar

Sarah completed her PhD in Biology at Heidelberg University, where she developed mathematical models for gene expression in bacteria. Her role at EMBL is shared between the Huber group and Bio-IT (Center for Statistical Data Analysis). She will support EMBL’s scientific community in statistical data analysis by providing consulting and courses.

Vladislav Kim

Vlad is a PhD student with a background in computational physics. He obtained his MSc degree from the University of Heidelberg with his graduate research focusing on population genomics of drug response in leukemia. At the moment he is continuing his work on genome-wide association study of CLL drug sensitivity. Additionally, Vlad is working on image analysis of 3D cell culture data.

Junyan Lu

Junyan has a PhD in Computational Biology and Drug Design from Shanghai Institute of Materia Medica, Chinese Academy of Sciences. His previous research focused on understanding mechanisms of drug response using integrated multi-omics technology and large scale ex-vivo drug testing approaches. In November 2015, he joined the Huber Group as a postdoctoral fellow and has worked on several projects since then. He is now working mainly on the MOFA project (Entwicklung computergestützter Methoden zur simultanen integrativen Analyse von Daten aus experimentellen “Multi-Omics” Ansätzen).

Thomas Naake

Thomas obtained his PhD in Biochemistry from the University of Potsdam, while conducting research at the Max Planck Institute of Molecular Plant Physiology in Potsdam-Golm. In November 2020 he joined the Huber group as a postdoctoral fellow. As a member of the SMART-CARE project, his research focuses on using proteomics and metabolomics data sets to understand better tumor biology, vulnerabilities, resistance mechanisms, and the recurrence of different cancer types.

Tobias Roider

Tobias is a physician scientist and postdoctoral fellow. In April 2021, he joined a collaborative research project (SIMONA) between the Huber Group at EMBL and the Dietrich Group at the Heidelberg University Hospital. His current research focuses on understanding intratumor heterogeneity within the lymph node niche using multimodal single cell applications.

Thomas Schwarzl

Tom has a PhD in Bioinformatics and Systems Biology from University College Dublin in Ireland. As EIPOD postdoctoral fellow, he is studying novel RNA-binding dynamics of metabolic enzymes. More …

Mike Smith

Mike joined EMBL as part of the de.NBI project where he is working on the development pipelines, workflows and computational approaches for large scale biological experiments. He has a PhD in computational biology from the University of Cambridge, UK.
More …